Literature DB >> 15823803

External otitis caused by infection with Pseudomonas aeruginosa or Candida albicans cured by use of a topical group III steroid, without any antibiotics.

Per Emgård1, Sten Hellström, Stig Holm.   

Abstract

CONCLUSIONS: Irrespective of the microbial agent, group III steroid solution cured external otitis efficiently in a rat model. The addition of antibiotic components to steroid solutions for the treatment of external otitis is of questionable validity.
OBJECTIVE: External otitis, caused by infection with either Pseudomonas aeruginosa or Candida albicans, was established in a rat model and the treatment efficacy of a group III steroid solution was studied.
MATERIAL AND METHODS: Three treatments were studied: (i) a group III steroid solution; (ii) a group I steroid combined with two antibiotic components; and (iii) a saline solution. A scoring scale was used to evaluate the characteristics of the ear canal skin. Bacteriological and fungal samples were collected for culturing and ear canal skin biopsies were taken for structural analyses.
RESULTS: It was possible to cause P. aeruginosa and C. albicans infections in an animal model. In the P. aeruginosa-infected animals, only the group III steroid treatment cured all the animals. In the C. albicans-infected animals, group III steroid treatment resolved external otitis faster than the other treatment modalities.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15823803     DOI: 10.1080/00016480510027529

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  7 in total

Review 1.  [Otitis externa: etiology, diagnostic and therapy].

Authors:  A Neher; M Nagl; A W Scholtz
Journal:  HNO       Date:  2008-10       Impact factor: 1.284

2.  The Role of Topical Thymoquinone in the Treatment of Acute Otitis Externa; an Experimental Study in Rats.

Authors:  Hasan Demirel; Cengiz Arlı; Tümay Özgür; Melek İnci; Recep Dokuyucu
Journal:  J Int Adv Otol       Date:  2018-08       Impact factor: 1.017

Review 3.  Otitis Externa.

Authors:  Susanne Wiegand; Reinhard Berner; Antonius Schneider; Ellen Lundershausen; Andreas Dietz
Journal:  Dtsch Arztebl Int       Date:  2019-03-29       Impact factor: 5.594

4.  [Topical immunomodulation. A milestone for the treatment of therapy-resistant noninfectious chronic external otitis?].

Authors:  P P Caffier; W Harth; B Mayelzadeh; H Haupt; H Scherer; B Sedlmaier
Journal:  HNO       Date:  2008-05       Impact factor: 1.284

5.  A quantitative model for dermal infection and oedema in BALB/c mice pinna.

Authors:  Erika Nahomy Marino-Marmolejo; Flor Yohana Flores-Hernández; Mario Alberto Flores-Valdez; Luis Felipe García-Morales; Ana Cecilia González-Villegas; Jorge Bravo-Madrigal
Journal:  BMC Microbiol       Date:  2016-12-12       Impact factor: 3.605

Review 6.  Multidrug resistance crisis during COVID-19 pandemic: Role of anti-microbial peptides as next-generation therapeutics.

Authors:  Sheetal Sharma; Panchali Barman; Shubhi Joshi; Simran Preet; Avneet Saini
Journal:  Colloids Surf B Biointerfaces       Date:  2021-12-20       Impact factor: 5.268

7.  The EDA-deficient mouse has Zymbal's gland hypoplasia and acute otitis externa.

Authors:  Jorge Del-Pozo; Denis J Headon; James D Glover; Ali Azar; Sonia Schuepbach-Mallepell; Mahmood F Bhutta; Jon Riddell; Scott Maxwell; Elspeth Milne; Pascal Schneider; Michael Cheeseman
Journal:  Dis Model Mech       Date:  2022-03-30       Impact factor: 5.758

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.